Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Revance Therapeutics (RVNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2024	06-2024	03-2024	12-2023	09-2023
Assets
Current Assets
Cash & Cash Equivalents	59,050	81,728	133,159	137,879	179,594
Marketable Securities	125,491	150,791	144,463	116,586	120,926
Receivables	48,263	36,088	29,887	27,660	25,414
Inventories	85,213	68,287	50,280	45,579	46,214
Other current assets	1,735	2,610	2,610	1,853	0
TOTAL	$329,687	$350,172	$369,686	$338,865	$388,519

Non-Current Assets
PPE Net	15,897	16,665	17,505	17,225	17,179
Intangibles	7,634	8,180	8,725	9,270	10,507
Other Non-Current Assets	108,346	113,887	112,203	113,094	116,282
TOTAL	$131,877	$138,732	$138,433	$139,589	$143,968

Total Assets	$461,564	$494,799	$508,119	$478,454	$532,487

Liabilities
Current Liabilities
Short Term Debt	20,991	25,217	5,000	5,151	9,860
Accounts payable and accrued liabilities	12,335	4,985	5,276	13,554	4,775
Accrued Expenses	34,022	47,172	40,311	52,863	53,493
TOTAL	$80,049	$93,632	$68,903	$89,224	$82,158

Non-Current Liabilities
Deferred Revenues	6,329	9,610	9,784	10,737	5,371
Other Non-Current Liabilities	458,995	462,937	466,486	470,415	472,215
TOTAL	$544,545	$530,905	$537,889	$540,834	$556,530

Total Liabilities	$624,594	$624,537	$606,792	$630,058	$638,688

Shareholders' Equity
Shares Outstanding, K	104,902	104,823	104,449	88,214	87,813
Common Shares	105	105	104	88	88
Retained earnings	-2,207,100	-2,168,985	-2,131,512	-2,078,360	-2,022,661
Other shareholders' equity	72	-26	-25	14	-13
TOTAL	$-163,030	$-129,738	$-98,673	$-151,604	$-106,201

Total Liabilities And Equity	$461,564	$494,799	$508,119	$478,454	$532,487